Navigation Links
Aria Analytics Receives JumpStart Investment
Date:11/7/2007

of testing include little or no sample preparation, quick turnaround times, applicability to a wide variety of markets, and portability.

"Currently, a number of tests are required to determine the specific chemical and physical properties that characterize raw materials and products," says Christina Vacca, chief executive officer of Aria. "These tests are time consuming, expensive, and/or require potentially dangerous reagents to prepare samples for testing. With Aria's process, we are able to perform a single test at a fraction of the cost and time and without the use of hazardous chemicals. One such use of the information generated by our technology is the ability to track changes in the samples that occur over time. "

In addition to the financial investment, Mark Smith, Entrepreneur-in- Residence from JumpStart's Acceleration Team, will be providing business development services to the company.

"Aria is yet another example of Northeast Ohio's strength in advanced technologies," Smith said. "We are excited about working with Chris to move the Aria technology closer to market acceptance."

This is JumpStart's 32nd investment in 24 companies. Other companies in JumpStart's portfolio include AcelleRX Therapeutics, AnalizaDx, FLX Micro, RSP Tooling, Synapse Biomedical, CardioInsight Technologies and Great Lakes Pharmaceuticals.

About Aria Analytics, Inc.

Aria Analytics is commercializing a novel platform analytical technology used to characterize liquids in industry and medical testing. This technology lowers both capital and operating costs per test. Prior to the availability of the Aria technology it was necessary to run a battery of tests on multiple laboratory instruments to obtain a profile of a specific sample. The Aria technology differentiates liquids by providing a unique acoustic signature during the drying process of the sample. Aria's mission is to provide sound analysis for industry and healthcare.

About JumpStart
'/>"/>

SOURCE JumpStart Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Lake Elsinore Family Caregiver Receives Free Power Wheelchair From The SCOOTER Store
2. DaVita Receives Civil Complaint
3. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
4. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
5. Edwards Lifesciences Receives CE Mark for Edwards SAPIEN Transcatheter Heart Valve
6. PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers
7. UT Southwesterns obesity research receives $22 million NIH Roadmap grant
8. Temple Emergency Medicine receives $1.8M to find best MRSA treatment
9. Prime Therapeutics Receives TIPPS Certification
10. Bioniche Receives $2 Million Government Grant For Market Development Related to its E. coli O157:H7 Cattle Vaccine
11. UCLA receives $22.5 million to explore the fundamental biology of mental disorders
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:TexSAn Heart Hospital Signs Agreement with Blue Cross and Blue Shield of Texas 2Health News:Indiana Blood Center Signs BIO-key(R) Contract 2Health News:Indiana Blood Center Signs BIO-key(R) Contract 3Health News:FDA Grants Over-The-Counter Clearance to GentleWaves(R) for the First Home Use Light-Based Device to Treat Wrinkles 2Health News:FDA Grants Over-The-Counter Clearance to GentleWaves(R) for the First Home Use Light-Based Device to Treat Wrinkles 3Health News:FDA Grants Over-The-Counter Clearance to GentleWaves(R) for the First Home Use Light-Based Device to Treat Wrinkles 4Health News:Public Health Experts Argue for Integrated Services to Avert 7 Million HIV Infections by 2010 2Health News:America's 50 best hospitals 2008 released by HealthGrades 2Health News:America's 50 best hospitals 2008 released by HealthGrades 3Health News:NEWSWEEK: Media Lead Sheet/March 3, 2008 Issue (on newsstands Monday, February 25) 2Health News:NEWSWEEK: Media Lead Sheet/March 3, 2008 Issue (on newsstands Monday, February 25) 3Health News:NEWSWEEK: Media Lead Sheet/March 3, 2008 Issue (on newsstands Monday, February 25) 4Health News:NEWSWEEK: Media Lead Sheet/March 3, 2008 Issue (on newsstands Monday, February 25) 5
Breaking Medicine Technology:Onyx Pharmaceuticals to Webcast Analyst Briefing on Development Program 2Dynatronics Receives 180-Day NASDAQ Extension 2ARKRAY, Inc. Receives FDA 510k Clearance on the Assure(R) Platinum Auto-Code Blood Glucose Monitoring System 2Kevin Niksarli M D Of Newsight Laser Center New York N Y Reminds Early Detection Critical to Slowing Progress of Glaucoma on 6 17 2009 49538 1Kevin Niksarli M D Of Newsight Laser Center New York N Y Reminds Early Detection Critical to Slowing Progress of Glaucoma on 6 17 2009 49538 2RSA Designated as the Leader in One Time Password Market by Frost 26 Sullivan 8936 1RSA Designated as the Leader in One Time Password Market by Frost 26 Sullivan 8936 2RSA Designated as the Leader in One Time Password Market by Frost 26 Sullivan 8936 3RSA Designated as the Leader in One Time Password Market by Frost 26 Sullivan 8936 4Cell Therapeutics Announces Final Results of its Fixed Price Exchange Offers for Any and All of its 24118 9 Million Convertible Notes Outstanding 49533 1Cell Therapeutics Announces Final Results of its Fixed Price Exchange Offers for Any and All of its 24118 9 Million Convertible Notes Outstanding 49533 2Cell Therapeutics Announces Final Results of its Fixed Price Exchange Offers for Any and All of its 24118 9 Million Convertible Notes Outstanding 49533 3